Stock Research: Labcorp

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Labcorp

NYQ:LH US50540R4092
91
  • Value
    88
  • Growth
    70
  • Safety
    Safety
    96
  • Combined
    97
  • Sentiment
    53
  • 360° View
    360° View
    91
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Labcorp Holdings Inc. provides comprehensive laboratory services to aid in healthcare decisions. The company operates in diagnostics and biopharma laboratory services, with key focus areas including oncology, women's health, autoimmune disease, and neurology. It serves through a network of patient service centers, branches, rapid response, primary, and specialty laboratories. In the last fiscal year, the company had a market cap of $20561 million, profits of $3624 million, revenue of $13009 million, and 70000 employees.

more

ANALYSIS: With an Obermatt 360° View of 91 (better than 91% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Labcorp are very positive. The 360° View is based on consolidating four consolidated indicators, with all four indicators above average for Labcorp. The consolidated Value Rank has an attractive rank of 88, which means that the share price of Labcorp is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 88% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 70, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The company is also safely financed with a Safety rank of 96. Finally, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 53. ...read more

more
Index
D.J. US Health Care
S&P 500
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 9-Apr-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
88 69 65 70
Growth
70 33 33 33
Safety
Safety
96 63 73 80
Sentiment
53 81 43 53
360° View
360° View
91 79 55 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
16 67 43 79
Opinions Change
50 68 11 50
Pro Holdings
n/a 71 67 13
Market Pulse
23 82 75 60
Sentiment
53 81 43 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
88 69 65 70
Growth
70 33 33 33
Safety Safety
96 63 73 80
Combined
97 58 67 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
93 35 28 35
Price vs. Earnings (P/E)
8 59 45 57
Price vs. Book (P/B)
51 39 49 64
Dividend Yield
97 81 86 84
Value
88 69 65 70
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
62 34 33 10
Profit Growth
100 49 20 57
Capital Growth
34 34 57 25
Stock Returns
34 57 59 69
Growth
70 33 33 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
28 41 60 48
Refinancing
95 47 42 54
Liquidity
100 65 76 83
Safety Safety
96 63 73 80

Similar Stocks

Discover high‑ranked alternatives to Labcorp and broaden your portfolio horizons.

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

Aramark

NYQ:ARMK
Country: USA
Industry: Restaurants
Size: X-Large
Full Stock Analysis

Capital One

NYQ:COF
Country: USA
Industry: Consumer Finance
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This is an all-around strong stock. It shows good value, high growth, safe financing, and positive professional sentiment. It is ideal for most buy-and-hold investors who value a good all-around stock.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: